Stryker Corporation (NYSE:SYK) Receives Average Rating of "Moderate Buy" from Analysts

Key Points

• Stryker Corporation has received an average rating of "Moderate Buy" from 21 analysts, with 15 buy ratings and 6 hold ratings, and a 12-month price target average of $432.24.
• In the latest quarter, Stryker reported an EPS of $3.13, exceeding estimates, along with a revenue of $6.02 billion, which is an 11.1% increase year-over-year.
• The company announced a quarterly dividend of $0.84 per share, with a dividend yield of 0.9%, reflecting a payout ratio of 44.50%.

Shares of Stryker Corporation (NYSE:SYK - Get Free Report) have received an average rating of "Moderate Buy" from the twenty-one ratings firms that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $432.2381.

SYK has been the subject of several recent analyst reports. UBS Group set a $408.00 target price on shares of Stryker in a research report on Monday, October 13th. Redburn Partners set a $420.00 target price on shares of Stryker in a research report on Thursday, September 18th. Rothschild Redb upgraded shares of Stryker to a "hold" rating in a report on Thursday, September 18th. Wells Fargo & Company increased their price objective on shares of Stryker from $435.00 to $445.00 and gave the company an "overweight" rating in a report on Friday, August 1st. Finally, Evercore ISI decreased their price objective on shares of Stryker from $418.00 to $410.00 and set an "outperform" rating for the company in a report on Tuesday, October 7th.

Stryker Price Performance

NYSE SYK opened at $381.86 on Friday. Stryker has a 52 week low of $329.16 and a 52 week high of $406.19. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. The stock has a market cap of $145.99 billion, a price-to-earnings ratio of 50.58, a price-to-earnings-growth ratio of 2.76 and a beta of 0.94. The company has a 50-day moving average price of $379.84 and a two-hundred day moving average price of $379.73.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, topping the consensus estimate of $3.07 by $0.06. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The firm had revenue of $6.02 billion during the quarter, compared to analysts' expectations of $5.92 billion. During the same quarter in the prior year, the firm earned $2.81 EPS. Stryker's quarterly revenue was up 11.1% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Analysts forecast that Stryker will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a $0.84 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker's dividend payout ratio (DPR) is 44.50%.

Insider Activity at Stryker

In other news, insider Viju Menon sold 500 shares of the stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the transaction, the insider directly owned 12,511 shares in the company, valued at $4,886,921.71. This trade represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the transaction, the director owned 3,222,108 shares of the company's stock, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.90% of the company's stock.

Institutional Trading of Stryker

A number of large investors have recently added to or reduced their stakes in SYK. Brighton Jones LLC boosted its holdings in Stryker by 15.4% during the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock worth $1,643,000 after buying an additional 609 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Stryker by 16.4% during the first quarter. GAMMA Investing LLC now owns 5,574 shares of the medical technology company's stock worth $2,075,000 after buying an additional 785 shares in the last quarter. Spire Wealth Management boosted its holdings in Stryker by 1.2% during the first quarter. Spire Wealth Management now owns 3,473 shares of the medical technology company's stock worth $1,293,000 after buying an additional 42 shares in the last quarter. Golden State Wealth Management LLC boosted its holdings in Stryker by 298.5% during the first quarter. Golden State Wealth Management LLC now owns 793 shares of the medical technology company's stock worth $295,000 after buying an additional 594 shares in the last quarter. Finally, HBK Sorce Advisory LLC boosted its holdings in Stryker by 5.0% during the first quarter. HBK Sorce Advisory LLC now owns 847 shares of the medical technology company's stock worth $315,000 after buying an additional 40 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.